• Aust Prescr · Aug 2019

    Review

    Venous thromboembolism: current management.

    • Hannah Stevens, Huyen Tran, and Harry Gibbs.
    • Alfred Health, Melbourne.
    • Aust Prescr. 2019 Aug 1; 42 (4): 123-126.

    Anticoagulation Is Indicated In Most Cases Of Venous ThromboembolismMonotherapy With Rivaroxaban Or Apixaban Is The Preferred Option For Most Adults With Acute Venous ThromboembolismThere Are No Recommended Dose Reductions For Rivaroxaban Or Apixaban In Venous Thromboembolism Unlike For Atrial FibrillationThe Initial Duration Of Anticoagulation Is Usually Three MonthsExtended Treatment With Low Dose Rivaroxaban Or Apixaban Is Effective In Preventing Recurrence In Patients With A Continuing Increased Risk Of Thromboembolism Both Drugs Have Low Rates Of Major Bleeding

      Pubmed     Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.

We guarantee your privacy. Your email address will not be shared.